Clinical Research Directory
Browse clinical research sites, groups, and studies.
Proteolytic Enzyme Induction Within the Human Myocardial Interstitium
Sponsor: VA Office of Research and Development
Summary
A robust release of endothelin-1-1 (ET) with subsequent ETA subtype receptor (ET-AR) activation occurs in patients following cardiac surgery requiring cardiopulmonary bypass (CPB). Increased ET-AR activation has been identified in patients with poor left ventricular (LV) function (reduced ejection fraction; EF). Accordingly, this study tested the hypothesis that a selective ET-AR antagonist (ET-ARA) administered peri-operatively would favorably affect post-CPB hemodynamic profiles in patients with a pre-existing poor LVEF.
Key Details
Gender
All
Age Range
60 Years - Any
Study Type
INTERVENTIONAL
Enrollment
29
Start Date
2008-07
Completion Date
2013-04
Last Updated
2026-08-13
Healthy Volunteers
No
Conditions
Interventions
1mg/kg sitaxsentan sodium
1mg/kg sitaxsentan sodium (intravenous bolus) performed immediately before separation from cardiopulmonary bypass and again at 12 hours after cardiopulmonary bypass.
2mg/kg sitaxsentan sodium
2mg/kg sitaxsentan sodium (intravenous bolus) performed immediately before separation from cardiopulmonary bypass and again at 12 hours after cardiopulmonary bypass.
Vehicle
Intravenous bolus performed immediately before separation from cardiopulmonary bypass and again at 12 hours after cardiopulmonary bypass.
Locations (1)
Ralph H. Johnson VA Medical Center, Charleston, SC
Charleston, South Carolina, United States